Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of H. Pylori in a High Clarithromycin and Metronidazole Resistance Area

NCT07146594 is registered in ClinicalTrials.gov with Athens Medical Center as lead sponsor.

NCT NCT07146594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of H. Pylori in a High Clarithromycin and Metronidazole Resistance Area
Lead sponsor
Athens Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 20, 2025
Completion date
May 1, 2026
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter eradication, helicobacter pylori gastritis